The collective motion of cells drives early embryonic events such as egg shell rotation^[@R1]^ and midgut invagination^[@R2]^ in *Drosophila* and epidermal morphogenesis in *C. elegans*^[@R3]^. Poor coordination is associated with pathological states, as cell sheets^[@R4]^, clusters^[@R5]^ and strands^[@R6]^ extravasate from tumors during cancer metastasis^[@R7]^. The coordination of cell movement is driven by a balance of mechanical stresses occurring at cell interfaces and between the cell and the extracellular matrix (ECM)^[@R8],\ [@R9],\ [@R10]^. The regulated maintenance of this balance determines the homeostatic movement of the epithelium along mucosal surfaces^[@R11]^ and the repair of epithelial wounds^[@R12],\ [@R13],\ [@R14]^.

Epithelial wound repair is driven by both the cooperation of distinct modes of migration and the coordination of mechanical force production which involves the assembly and contractility of disparate actin architectures across diverse timescales. At the early stages of wound repair, cells proximal and distal to the wound migrate to close the space^[@R15],\ [@R16],\ [@R17]^. Migration through "crawling" is driven by forward lamellipodial protrusions, which couple to focal adhesions and induce contraction and rearward motion of the substrate^[@R8]^. By contrast, at later stages of wound repair, lamellipodial protrusions coexist with multi-cellular actomyosin bundles, called "purse strings", which assemble at the wound periphery ("leading edge")^[@R18]^ and contract laterally to pull cells forward^[@R19]^. Purse string formation and the dynamics of closure depend upon the curvature of the wound^[@R20],\ [@R21]^ and can occur in the presence^[@R8]^ or absence^[@R22]^ of underlying adhesion. Consequently, the relationship between contractility and adhesion generated via purse strings is unclear as is the extent to which purse strings cooperate with lamellipodial protrusion to drive efficient wound closure.

In this study, we investigate the cooperation between Arp2/3-driven lamellipodial protrusion and actomyosin purse string contraction in controlling the mechanical output within epithelial monolayers after inducing single cell wounds by laser ablation. Monolayers adhere to substrates of varying rigidity and constant adhesivity. After ablation, we correlate the dynamics of closure with the applied mechanical work subject to perturbation in substrate stiffness and pharmacology. Specifically, we aim to identify the extent to which cells regulate their modes of migration to optimize the collective dynamic and mechanical outputs of the monolayer during closure. We identify mechanisms by which these outputs are regulated by the cytoskeleton and focal adhesions.

Substrate Stiffness Regulates Monolayer Viscoelasticity {#S1}
=======================================================

Confluent monolayers, either of MDCK or Caco-2 cells, are adhered to collagen-coated polyacrylamide (PA) gels ([Fig 1a](#F1){ref-type="fig"}). A 337 nm laser ablates a single cell and creates a small hole in the elastic gel ([SFig 1, Supplementary Note](#SD1){ref-type="supplementary-material"}). Ablation induces quick outward retraction in the surrounding cells for \~120 s, as the wound reaches its maximum size ([Fig 1b](#F1){ref-type="fig"}, [Movie 1](#SD1){ref-type="supplementary-material"}). By applying particle image velocimetry (PIV) to differential interference contrast images (DIC), we quantify the velocity of the retracting monolayer over time ([Fig 1c](#F1){ref-type="fig"}). We find that the rate of the retraction decays exponentially with time, with a characteristic timescale, *τ*~*0*~. Applying a Kelvin-Voigt model, *τ*~*0*~ provides an approximation for the ratio of the monolayer viscosity *η*~*m*~ to monolayer modulus *E*~*m*~ ([Fig 1d](#F1){ref-type="fig"}). We find that *τ*~*0*~ varies between 10 and 30 s, roughly consistent with F-actin (filamentous actin) disassembly during this period ([SFig 2, Movie 2](#SD1){ref-type="supplementary-material"}). We find that *τ*~*0*~ decreases for increasing substrate rigidity, suggestive of an increase in monolayer elasticity and/or a decrease in monolayer viscosity ([Fig 1e](#F1){ref-type="fig"}). Thus, cell-substrate interactions contribute to the viscoelasticity of the epithelial monolayer. We show that these results are not limited by cell-ECM adhesion levels ([SFig 3](#SD1){ref-type="supplementary-material"}).

Substrate Stiffness Determines Cellular Actin Architectures {#S2}
===========================================================

Between 120 s and 20 min, F-actin assembles into both lamellipodial protrusions and actomyosin bundles within cells at the leading edge of the wound concomitant with the establishment of focal adhesions ([Fig 2a](#F2){ref-type="fig"}, [Movies 3, 4, 5](#SD1){ref-type="supplementary-material"}). The proportion of cells that exhibit lamellipodia or purse string architectures at the leading edge vary during closure of the wound ([Fig 2b](#F2){ref-type="fig"}). While it is understood that lamellipodial protrusion and cell spreading are associated with enhanced rigidity of the substrate^[@R23],\ [@R24]^, it has thus far remained unclear the extent to which coordination between lamellipodia and purse string assembly depends on substrate rigidity during wound closure.

We measure the extent of lamellipodial protrusion and actin purse string formation as a function of substrate rigidity *E* at the leading edge of the wound over time. To this end, we trace the boundary of the wound through F-actin fluorescence intensity in MDCK cells stably transfected by F-tractin ([Fig 2b](#F2){ref-type="fig"}). We trace the leading edge boundary of length *L* ([SFig 4](#SD1){ref-type="supplementary-material"}), which yields the area of the wound, *A*. No assumption is made regarding the shape of the wound. We also trace the lamellar border across the wound, as defined by the peak in actin fluorescence intensity to define the area enclosed by the lamella, *A*~*L*~. Therefore, *A*~*L*~ represents the sum of the wound area and the area of the lamellipodia. The quotient *ψ = (A*~*L*~ *-- A)/A*~*L*~, where *A*~*L*~≥*A*, quantifies the extent of total lamellipodial protrusion and is related to the total number of cells at the leading edge that exhibit lamellipodia ([SFig 4](#SD1){ref-type="supplementary-material"}). Therefore, larger *ψ* corresponds to a predominantly lamellipodial leading edge, while smaller *ψ* corresponds to a predominantly purse string edge. We further distinguish between lamellipodia and purse string by calculating the local nematic order of actin filaments ([SFig 5](#SD1){ref-type="supplementary-material"})^[@R25]^. We find that lamellipodial edges have lower F-actin alignment than purse string edges. In addition, we complement these calculations at the leading edge with transient transfections, where individual cells within the monolayer express fluorescent F-actin, providing single cell statistics ([Fig 2c](#F2){ref-type="fig"}). The relative abundance of lamellipodial protrusion versus purse string evolves as a function of *A* ([Fig 2d](#F2){ref-type="fig"}). While the wound is large (*A* \>1200 μm^2^) and time is short (t\< 20 min) there is significant F-actin assembly but protrusions are small, and therefore *ψ* is low. As the wound heals and *A* decreases from its initial value, lamellipodial protrusion area reaches a maximum, *ψ*~*max*~. After this point, *A* decreases for the remainder of closure and there is less lamellipodial protrusion and more formation of purse string. Within a single experiment for *E*=12.2 kPa, *ψ*varies slightly (δψ~single~ = ψ~max~-ψ~min~ = 0.29 +/− 0.09, N=10), whereas the variation in *ψ* across control experiments is large (δψ~all~ = 0.7, N=10).

The proportion of lamellipodia protrusion versus purse string also varies with substrate rigidity ([Fig 2d](#F2){ref-type="fig"}-inset). For low rigidity (E \< 4.3 kPa), *ψ*~*max*~ is low, indicating the predominance of purse strings. By contrast, for high rigidity (E \> 4.3 kPa), *ψ*~*max*~ is high, indicative of principally lamellipodial morphology. While *ψ* is a measure of the proportion of area covered by each architecture, we also measure the proportion of cells at the leading edge expressing each architecture individually. In the case of single cell transfections, we qualitatively categorize each cell as initially choosing either a lamellipodial or purse string morphology, as we image only single cells and not the entire wound boundary. Indeed, we confirm through single cell transfection that the dominant F-actin structure depends on substrate stiffness ([Fig 2e](#F2){ref-type="fig"}). The proportion of lamellipodia and purse string varies for substrate stiffnesses ranging between 1.3 kPa and 55 kPa and also for glass coverslips ([Supplementary Note](#SD1){ref-type="supplementary-material"}).

Cell morphology and F-actin architecture can be modulated with pharmacological treatments to bias the formation of lamellipodia or purse strings. Blebbistatin, a myosin ATPase inhibitor, limits the formation of the purse string, and motion is driven by Arp2/3 lamellipodial protrusion ([Fig 2f](#F2){ref-type="fig"})^[@R26]^. Similarly, SMIFH2 inhibits formin-based F-actin nucleation, and will restrict purse string formation^[@R27]^. In contrast, CK666 inhibits Arp2/3 polymerization, minimizing lamellipodial protrusions and promotes the formation of purse strings ([Fig 2g](#F2){ref-type="fig"})^[@R28]^. Characterization of the F-actin architecture through *ψ*~*max*~ captures the differences amongst drug and untreated wound closures ([Fig 2h](#F2){ref-type="fig"}). Thus, these two primary architectures are controllable through both substrate rigidity *and* pharmacological perturbation.

Closure Rate is Independent of Substrate Rigidity {#S3}
=================================================

We next assess the impact of the balance of F-actin architecture of cells at the leading edge on wound closure speed. Wound closure rate is measured in two ways. First, as indicated previously, the perimeter of the leading edge of length *L* is traced to determine the wound area *A* and tracked over time ([Fig 3a](#F3){ref-type="fig"}). Second, the cumulative displacement field $\overset{\rightarrow}{x}$, and the velocity $\overset{\rightarrow}{v}$, of the monolayer distal to the leading edge ("bulk") are calculated using PIV on DIC images ([Fig 3b](#F3){ref-type="fig"}). The rate of change in *A* predominantly reflects the motion of the leading edge, and the rate of change in the strain, *ε*, reflects the motion of the bulk cells across a fixed field of view ([Methods](#S7){ref-type="sec"}). *A* and *ε* are highly correlated, indicating that motion at the leading edge is correlated to the movement of bulk cells distal to the wound ([Fig 3c](#F3){ref-type="fig"}-inset). *A* decreases exponentially with timescale, *τ*~*1*~, and transitions to a second, shorter timescale, *τ*~*2*~ in 45% of wounds ([Fig 3c](#F3){ref-type="fig"}). The latter correlates with very small wounds (*L*\<100 μm), at which point the leading edge is close to the ablated hole in the gel. We therefore restrict our analysis to wounds with *L* \> 100μm and approximate the characteristic timescale for closure as the larger timescale, *τ*~*1*~.

Despite differences in monolayer viscoelasticity ([Fig 1e](#F1){ref-type="fig"}), we find that the wound closure rate is independent of substrate rigidity, as we find no statistically significant correlation (N=36) between *τ*~*1*~ and *E* ([Fig 3d](#F3){ref-type="fig"}). However, as there is a difference in the rates of motion between lamellipodia and purse string in single cells ([Fig 2c](#F2){ref-type="fig"}), we sought to understand how different architectures regulate closure speed for the wound. Given the presence of both lamellipodia and purse string for *E*\>4.3 kPa, the experiments are partitioned into cases in which the maximum lamellipodial area at the leading edge is more than 50% ("LP") or less than 50% ("PS") of the total wound area as found through visual inspection of DIC images. LP wounds have shorter *τ*~*1*~ than PS wounds, indicating that epithelial wounds with a predominantly lamellipodial leading edge heal faster, consistent with [Fig. 2c](#F2){ref-type="fig"}. For *E*\<4.3 kPa, all closures are purse string mediated and faster than purse string closure on more rigid substrates ([Fig 3e](#F3){ref-type="fig"}). Thus, we find that there is a critical rigidity *E\**, for which there is a shift in the dynamics of F-actin architecture-specific closure rates. A similar shift is observed at a different *E\** for Caco-2 monolayers ([SFig 6](#SD1){ref-type="supplementary-material"}).

In addition to stochastic variations in the balance of F-actin architectures within cells at the leading edge, pharmacological perturbations to the balance of F-actin architecture can influence the rate of closure. On soft substrates (*E* =1.8 kPa) for which the purse string dominates, blebbistatin treatment reduces the strain rate ([Fig 3f](#F3){ref-type="fig"}). Conversely, the strain rate for closures on stiffer substrates (E=12.2 kPa) are less affected by blebbistatin treatment consistent with lamellipodial closures being the standard closure mode. Thus, motion is most sensitive to myosin inhibition for E\<E\* due to the presence of actomyosin purse string and less sensitive for *E\>E\** due to the majority presence of lamellipodia.

Closure Rate and Work Yield a Constant Effective Power {#S4}
======================================================

Using traction force microscopy (TFM) for E\>E\* and monolayer cell densities 1500\< *ρ*\<2500 cells mm^−2^ ([Fig 4a](#F4){ref-type="fig"}), we define the local force $\overset{\rightarrow}{F}$ ([Fig 4b](#F4){ref-type="fig"}) and strain energy, ω ([Fig 4c](#F4){ref-type="fig"}). The total strain energy for a wound is calculated as *W=∑ω* for a wound of length *L* with a thickness 2*δ*~*+/−*~ = 8 μm at the leading edge ([Fig 4b,c](#F4){ref-type="fig"}, [SFig 7](#SD1){ref-type="supplementary-material"}, [Methods](#S7){ref-type="sec"}). The strain energy per unit time during closure is approximately constant within a single wound, giving the rate of work output P\* ([Fig 4d](#F4){ref-type="fig"}). We find no statistical difference between P\* when we separate wounds into PS (*ψ*~*max*~\<0.3) and LP (*ψ*~*max*~\>0.3) phenotypes for closures on *E*=12.2 kPa substrates ([Fig 4e](#F4){ref-type="fig"}, [SFigs 5, 7](#SD1){ref-type="supplementary-material"}). Additionally, the average velocity *v* during closure is determined by a linear fit to *L(t)* ([Fig 4f](#F4){ref-type="fig"}), consistent with the weakly exponential decrease in *A(t)* seen in [Fig 3](#F3){ref-type="fig"}. As such, wounds close with a constant energy density *W*/*L* ([Fig 4g](#F4){ref-type="fig"}, [Methods](#S7){ref-type="sec"}). When wounds are pharmacologically inhibited from closing, *W* is not strongly dependent on *L* ([SFig 7, Movie 6](#SD1){ref-type="supplementary-material"}).

We next investigate whether the energy density of a wound is set by the F-actin architecture. Indeed, the energy density is lower for LP than for PS ([Fig 4h](#F4){ref-type="fig"}). Consistent with single cell and PIV measurements ([Fig 2c](#F2){ref-type="fig"}, [3e](#F3){ref-type="fig"}), closure velocities are higher with LP than with PS ([Fig 4i](#F4){ref-type="fig"}). Surprisingly, the average change in energy density precisely counter-balances the velocity difference between the two closure types. Therefore, the product of the energy density and the wound closure velocity, what we term the effective power, *P*, of the wound is conserved across phenotypes at a constant substrate stiffness, consistent with the slope of *W(t)* ([Fig 4j](#F4){ref-type="fig"}, [SFig 7](#SD1){ref-type="supplementary-material"}). The effective power represents the mechanical work transmitted to the substrate per unit time at the leading edge since both phenotypes yield forward motion ([Methods](#S7){ref-type="sec"}).

To test the robustness of the relationship between F-actin architecture and mechanical work, we induce LP and PS phenotypes through blebbistatin and CK666 drug treatments respectively ([Movie 7](#SD1){ref-type="supplementary-material"}). Overall, any perturbation to actin assembly decreases the magnitude of the mechanical work ([Fig 4k](#F4){ref-type="fig"}), suggesting that the work is maximized for mixed architectures. Similar effects are seen when inhibiting Rho-associated protein kinases and microtubule assembly ([Movie 8](#SD1){ref-type="supplementary-material"}). Consistent with the LP and PS phenotypes in control (untreated) samples, the energy densities of blebbistatin-induced lamellipodial wounds are less than CK666-induced purse strings ([Fig 4k](#F4){ref-type="fig"}), with no significant differences in the velocities of these two groups ([Fig 4l](#F4){ref-type="fig"}). As observed previously, the effective power remains constant across LP and PS phenotypes at a given substrate stiffness ([Fig 4m](#F4){ref-type="fig"}).

Total F-actin is Constant During Morphological Transformation {#S5}
=============================================================

To understand the mechanism by which a wound maintains a constant energy density during closure, we quantify F-actin content at the wound edge while *ψ* decreases. The decrease in *ψ* during wound closure is due to the transformation of F-actin architecture within a cell from a lamellipodium to a purse string. Prior to this conversion, the lamellar actin moves at a constant speed ([Fig 5a](#F5){ref-type="fig"}). The lamellipodia then ceases to protrude and the lamellar actin surpasses the lamellipodial edge to become the actin purse string ([Fig 5a,b](#F5){ref-type="fig"}). Concomitantly, the purse string increases in F-actin fluorescence intensity locally ([Fig 5c](#F5){ref-type="fig"}, [SFig 8](#SD1){ref-type="supplementary-material"}). This mechanism is similar but opposite in direction to what has been observed for lamellipodium to lamellar F-actin flow in single cells^[@R29]^. The rate at which F-actin decreases in the lamellipodium, m~LP~ is strongly correlated with the rate of increase in purse string F-actin intensity, m~PS~. Comparing the integrated fluorescence intensities, we find that there is sufficient F-actin in the lamellipodium to account for the increase in F-actin in the purse string and within the cell body ([Fig 5d](#F5){ref-type="fig"}), suggesting that *de novo* actin polymerization may not be necessary to form the purse string. By contrast, there is no significant increase in purse string/lamellar band intensity within pharmacologically perturbed wounds ([SFig 9](#SD1){ref-type="supplementary-material"}). These results suggest that lamellipodial F-actin reinforces the lamellar band to form the purse string through the rearrangement of existing F-actin and/or (de)polymerization to keep the total F-actin constant ([Fig 5e](#F5){ref-type="fig"}). Although this rearrangement decreases the total amount of F-actin, *I*~*γ*~, at the leading edge ([Fig 5f](#F5){ref-type="fig"}), the density of F-actin *ρ= I*~*γ*~ */L increases* ([Fig 5g](#F5){ref-type="fig"}) during closure.

During this decrease in *I*~*γ*~, we find that the amount of myosin in the lamella/purse string is proportional to the amount of F-actin ([Fig 5h--j](#F5){ref-type="fig"}, [SFig 8](#SD1){ref-type="supplementary-material"}). Separately, we show that changes in F-actin content affect the force of the lamella/purse string ([Fig 5k](#F5){ref-type="fig"}). Taken together, this suggests that both myosin and F-actin content are moderated to maintain the constant average force measured through TFM during the transition from lamellipodia to purse string.

Differential Friction Underlies a Constant Effective Power {#S6}
==========================================================

To explain the origin of power balance between LP and PS wounds, we introduce an active adherent vertex model that simulates collective cell dynamics at the leading edge of the wound ([Figs 6a--b](#F6){ref-type="fig"}, [Movie 9, Supplementary Note](#SD1){ref-type="supplementary-material"}, [Methods](#S7){ref-type="sec"})^[@R30],\ [@R31],\ [@R32]^. As observed in experiments, the wound area decays exponentially with a characteristic timescale *τ*~*1*~ ([Fig 6c, 3c](#F6){ref-type="fig"}). Additionally, *in silico* wounds also exhibit a constant strain energy density and velocity ([Fig 6d](#F6){ref-type="fig"}, [4f,g](#F4){ref-type="fig"}).

Cells at the leading edge begin motion by protrusive crawling, which stochastically transitions to a purse string at a rate *k*~*ps*~, resulting in an increased tension at the leading edge. We simulate the closure dynamics of an initially circularly shaped wound for a range of purse string assembly rates, *k*~*ps*~ (0.50--2.00 hr^−1^) and different values of substrate stiffness. Consistent with *ψ*~*max*~ used experimentally, we classify wound repair as purse string dominant if the mean proportion of the wound perimeter covered by purse string is greater than 50% (PS), and lamellipodia dominant (LP) if the purse string coverage is less than 50% ([SFig 5](#SD1){ref-type="supplementary-material"}). When cell-substrate adhesion lifetimes vary between lamellipodial and purse string cells such that 2.5\**k*~*off*~^*PS*^=*k*~*off*~^*LP*^ ([Fig 6e](#F6){ref-type="fig"}), mechanical measurements are in quantitative agreement with experimental data. We find that the closure rate increases with substrate stiffness for purse string closure, while lamellipodial closure rates show no dependence on stiffness ([Fig 6f](#F6){ref-type="fig"}). Prolonged cell-substrate adhesion lifetime on purse string edges is necessary for sensitivity to substrate stiffness ([SFig 10](#SD1){ref-type="supplementary-material"}).

Our model allows us to investigate the role of contractile and protrusive motilities on wound closure dynamics and traction forces generated on the substrate. We show that the energy density of purse strings is higher than lamellipodial protrusion ([Fig 6g](#F6){ref-type="fig"}) and that the velocity of protrusion is faster than the purse string ([Fig 6h](#F6){ref-type="fig"}) as found experimentally ([Fig 4h,i](#F4){ref-type="fig"}). Additionally, the invariance in effective power between the phenotypes is observed ([Fig 6i](#F6){ref-type="fig"}). Interestingly, these results only hold if cell-substrate adhesions have a longer attachment time for purse strings than for lamellipodial cells ([Fig 6j](#F6){ref-type="fig"}, [SFig 10](#SD1){ref-type="supplementary-material"}). Seen in both experiments and simulations, focal adhesion orientations differ between the two phenotypes consistent with previous results ([Fig 6k--m](#F6){ref-type="fig"})^[@R12]^. The necessary asymmetry in adhesion lifetimes between purse strings and lamellipodia required to maintain a constant effective power is consistent with the experimentally measured asymmetry in focal adhesion size ([Fig 6n](#F6){ref-type="fig"}).

Since differential rates of attachment and detachment of focal adhesions will lead to differences in cell-substrate friction^[@R33]^, we calculate the effective friction between the monolayer and the substrate, given by the ratio of the forces along the leading edge to the velocity of closure $\xi = < |\overset{\rightarrow}{F}| > /v$. Since the forces can be measured directly, our estimation is model-independent. Consistent with the difference in focal adhesion size, we find that lamellipodial wounds exhibit less friction than purse string wounds on 12.2 kPa substrates, a necessary consequence for the balance of effective power ([Fig 6o](#F6){ref-type="fig"}). In agreement with experimental data, we find a significantly higher effective friction for purse string simulations ([Fig 6o](#F6){ref-type="fig"}). Furthermore, by varying $k_{off}^{ps}$ we see that an increase in effective friction corresponds to an increase in wound closure time^[@R34]^ ([SFig 10](#SD1){ref-type="supplementary-material"}).

Using the F-actin cytoskeleton, tissues generate active forces, and the balance of these forces against external loading and resistance is referred to as "tensional" or "energy" homeostasis^[@R35],\ [@R36]^. Previous studies have shown that to maintain mechanical homeostasis in cell colonies, traction stresses localize to colony boundaries^[@R37]^, and that the total elastic strain energy increases linearly with the size of the colony^[@R38],\ [@R39]^. In addition, traction stresses localize to the leading edge of migrating cell monolayers^[@R8],\ [@R12]^. Similarly, in wound healing, traction stresses localize to the wound boundary ([Movie 10](#SD1){ref-type="supplementary-material"}) and drive the elastic strain energy to decrease linearly with time, potentially suggesting other dissipative effects including shape fluctuation^[@R40]^ and loss of cells^[@R41],\ [@R42]^. However, the strain energy also decreases linearly with wound perimeter yielding a constant *W/L* within an experiment, suggestive of homeostatic regulation of leading edge tension during the dynamics of closure. While *W/L* varies with architecture across experiments, the effective power does not, as the velocity is inversely related to the energy density, and thus crawling and purse string compensate each other. This compensation is regulated by substrate stiffness, actomyosin content and focal adhesion stability, which may also be applicable to single cell studies^[@R43]^. Together, the results presented here relate the regulation of cytoskeletal machineries to the regulation of mechanical energy at tissue-scales.

Methods {#S7}
=======

Polyacrylamide Gel Formation {#S8}
----------------------------

Polyacrylamide gels are polymerized onto coverslips of 25mm diameter (\#1.5, Dow Corning). Briefly, the coverslips are treated with a combination of aminopropylsilane (Sigma Aldrich) and glutaraldehyde (Electron Microscopy Sciences) to make the surface reactive to the acrylamide. Varying concentrations of bis-acrylamide are mixed with 0.05% w/v ammonium persulfate (Fisher BioReagents) to yield a gel with an elastic modulus *E* of 1.5 kPa to 55 kPa. 40nM beads (Molecular Probes) are embedded in the gel mixture prior to polymerization. The ratios of polyacrylamide to bis-acrylamide for the gels used in this study are 5%:0.1% (*E*=1.3 kPa) 5%:0.175% (*E*=1.8 kPa), 7.5%:0.153% (*E*=4.3 kPa), 7.5%:0.3% (*E*=8.6 kPa), 12%:0.086% (*E*=12.2 kPa), 12%:0.145% (*E*=16 kPa), 12%:0.19% (*E*=24 kPa), and 12%:0.6% (*E*=55 kPa)^[@R44],\ [@R45]^.

Before the gels are fully polymerized, 9 μl of the gel is added to the coverslip and covered with another coverslip, which has been made hydrophobic through treatment with Rain-X®. The gels are polymerized on the coverslips for 30 minutes at room temperature. The gels are then reacted with the standard 2mg/mL Sulfo-SANPAH (Thermo Fisher Scientific) protocol^[@R45]^. The surface of the gels is then coated with rat tail collagen Type I (Corning®; high concentration). Concentration of collagen used range between (0.01 -- 1 mg/mL) to establish the role of adhesivity on traction force measurement ([SFig 3](#SD1){ref-type="supplementary-material"}). In the main text, we limit the scope to 1 mg/mL collagen to not limit lamellipodial activity. The reaction proceeds for 2 hours in the dark, and the coverslips are then rinsed with 1X PBS.

Cell Culture {#S9}
------------

Madin-Darby Canine Kidney (MDCK.2) cells (CRL-2936™; ATCC, Manassas, VA) were maintained in Eagle's Minimum Essential Medium (ATCC), supplemented with 10% fetal bovine serum (GIBCO Life Technologies) and 1% penicillin/streptomycin at 37°C and 5% CO~2~ in a humidified incubator. Early passage cells (\< 20 passages) were used for experiments. Similarly, Caco-2 (HTB-37™; ATCC, Manassas, VA) were maintained in the same culture conditions with the exception of 20% fetal bovine serum. Caco-2 cells were used primarily for their large size which enables superior visualization of their cell cytoskeleton during wound repair.

F-TRActin Stable Line Transfection {#S10}
----------------------------------

MDCK.2 cells were stably transfected with plasmid construct encoding for FTRActinEGFP (kind gift from Sergey Plotnikov, University of Toronto). Briefly, cells were transfected using FuGENE®HD where 2 μg of the DNA plasmid was added to the transfection reagent and added to a cell dish. Cells were incubated for over 24 hrs with the plasmid to complete the transfection process. Following 1 week of incubation with a selection media containing G418 (Mirus Bio LLC) at 0.5mg/mL, population of cells were selected based on fluorescently expressing the construct. The isolated population were cultured and expanded on the selective media and used for experimental purposes.

LifeAct Transient Transfection of Caco-2 {#S11}
----------------------------------------

Transfection was performed on Caco-2 cells using Lipofectamine 3000 (Life Technologies). Briefly, 3.75 μl of Lipofectamine 3000 was added to 125 μl of serum free media. 2.5 μg of GFP-LifeAct DNA (Bement Lab, University of Wisconsin-Madison) and 5 μl of P3000 reagent were added to the mixture. The solution was mixed and incubated at room temperature for 5 minutes before being added to 70% confluent cells in a drop-wise manner. Cells were incubated overnight at 37°C before imaging.

Laser Ablation and Time Lapse Imaging {#S12}
-------------------------------------

Laser ablation was performed using a 435nm laser (Andor Technology, Belfast, Northern Ireland). A 60X oil-immersion objective (Leica Microsystems) was used for ablation and the laser power was held between 60% and 65%. Images were acquired at 5 second intervals for the first 20 minutes following ablation with a confocal microscope (Andor Technologies, Belfast, Northern Ireland). Images were then collected at 5 minute intervals until wound closure.

Strain Calculation {#S13}
------------------

We calculate the strain ε of the bulk cells from the divergence of the cumulative displacement field, $\varepsilon = < \overset{\rightarrow}{\nabla} \cdot \overset{\rightarrow}{x} >$ and the subsequent strain rate $\overset{˙}{\varepsilon}$ of the monolayer is the time rate of change of the strain in the linear regime.

Traction Force Microscopy {#S14}
-------------------------

Traction force microscopy is used to measure the forces exerted by cells on the substrate^[@R45]^. 'Force-loaded' images (with cells) of the beads embedded in the polyacrylamide gels were obtained using a 60X oil-immersion objective (Leica Microsystems). The 'Null-force' image was obtained at the end of each experiment by adding trypsin to the cells for 1 hour. If the wound was exceedingly large (i.e. of the size of the image), the ablated image was used for the null-force image. Images were aligned to correct drift (StackReg for ImageJ)^[@R46]^ and compared to the reference image using particle imaging velocimetry (PIV) software (<http://www.oceanwave.jp/softwares/mpiv/>) in MATLAB to produce a grid spacing of 7.0 μm. Forces can be reliably measured between 4.3 and 24 kPa and are calculated using custom written code by Ulrich Schwarz^[@R45]^.

The traction forces are used to calculate the energies of deformation in the substrate using the spatial distribution of forces $\overset{\rightarrow}{F}$ and displacements $\overset{\rightarrow}{x}$. Since lamellipodia and purse strings have been shown to apply forces in different directions^[@R12]^, we choose a directionally-independent metric (the strain energy *ω*) as opposed to summing up individual force contributions. Consequently, the effective power is the rate at which all mechanical work is done instead of isolating the amount of work done in the direction of motion, since traction forces in any direction can result in motion. The spatial distribution of *ω* is calculated, for each coarse-grained grid size, using the equation $\omega = \frac{1}{2}\overset{\rightarrow}{F} \cdot \overset{\rightarrow}{x}$. The total strain energy *W* for a given geometry is calculated by summing up the local values of ω within a range of 8 μm (\~size of the hot-spots in strain energy maps) at the leading edge. Forces along the leading edge are reliably calculated when wounds are far from the ablation-induced hole in the traction force substrate. Therefore, we apply a wound perimeter cutoff and only report forces for wounds greater than 100 μm in perimeter. For 12.2 kPa substrates, traction substrate damage does not affect force measurements with this perimeter cutoff in 83% (N=29 of 36) of wounds.

We focus on substrate stiffnesses *E* = 12.2 kPa when studying the effects of actin structure within cells at the wound edge, because LP and PS phenotypes are approximately equally likely allowing for sufficient statistics for both phenotypes ([SFig 7](#SD1){ref-type="supplementary-material"}).

Immunofluorescence Microscopy {#S15}
-----------------------------

Cells were fixed with a solution of 4% paraformaldehyde in PBS and permeabilized with 0.2% Triton X-100. The cells were then blocked with 1% BSA in PBS at room temperature for 1 hour, incubated with primary antibodies for Paxillin (Rabbit monocolonal \[Y113\] to Paxillin, Abcam ab32084; 1:250 dilution) and E-Cadherin (Rat monoclonal \[DECMA-1\] to E Cadherin, Abcam ab 11512; 1:200 dilution) in PBS for 1 hour at room temperature. The samples were incubated with complimentary secondary antibodies in PBS for 1 hour at room temperature. The secondary antibodies used were Alexa Fluor 647 (Donkey anti-Rabbit, Abcam ab 150075, 1:500 dilution) and Alexa Fluor 405 (Goat anti-Rat, Abcam ab 175671, 1:500 dilution). Phalloidin staining was performed with Alexa Fluor 488 Phalloidin (Life Technologies; 1:40) diluted in PBS with 1% BSA at room temperature for 20 minutes. Images were taken with a 60X oil immersion objective. Analysis was performed with ImageJ.

Super-resolution Microscopy {#S16}
---------------------------

Ablated wounds were fixed in 4% paraformaldehyde and stained for F-actin using SiR-Actin (Cytoskeleton Inc. CY-SC001, 1:1000 dilution) and p-myosin light chain2 (Rabbit, S15 - Cell Signaling 3617s \#9284, 1:250 dilution). To visualize spatial distribution of myosin, we used Atto 594 (Anti-Rabbit Atto 594, Sigma Aldrich 77671, 1:500 dilution) as a secondary antibody tailored for super resolution imaging. Super resolution imaging was performed on the Abberior STED system (Abberior Instrument GmbH -- Pulsed STED laser \@775nm) using a water immersion lens 1.3NA. Images were taken with a scanning resolution of 20nm and 2.5D scan line.

Pharmacological Treatments {#S17}
--------------------------

Formin FH2 domain inhibitor (SMIFH2) was purchased from MilliporeSigma (34409) and used at a 10μM concentrations throughout all the experiments. Myosin II inhibitor ((−)Blebbistatin) was purchased from Sigma Aldrich (B0560) and used at a concentration of 50 μM unless otherwise noted. Arp2/3 inhibitor (CK666), purchased from Tocris (3950) and used at 200 μM concentration. All inhibitors were reconstituted in DMSO at high stock concentration and diluted in media to their appropriate concentration without any further purification.

Focal Adhesion Analysis {#S18}
-----------------------

Focal adhesion size and orientation were calculated using the "Analyze Particle" plugin in Fiji (ImageJ software)^[@R47]^. A threshold was applied to confocal images stained for paxillin, and the focal adhesion is fit to an ellipse with a given area. The angle of orientation is determined as the angle between the major axis of the fitted ellipse and either the vector normal to the purse string (for purse strings) or the vector normal to the nearest lamellipodial protrusion (for lamellipodia).

Myosin Intensity Calculations {#S19}
-----------------------------

The fluorescence intensities of myosin filaments were determined on super resolution images through spot tracking in Imaris software (Bitplane AG, Zurich, Switzerland). Myosin were found as "spots" with 200 nm diameter.

Cell-based computational model {#S20}
------------------------------

The model is implemented using Surface Evolver^[@R48]^. A wound is generated by removing cells within a circle of radius of 22.5 μm from a colony of 250 cells. The vertices surrounding the wound are then moved onto the edge of the circle, and the system relaxed so that all wound vertices lie on the perimeter of the circle and the system is at an energy minimum. To initiate gap closure, cells around the wound are set to the crawling mode. We then run the simulation until closure. At each time step we update adhesions binding, cell modes, perform neighbor exchanges and apply mechanical and active forces on vertices.

Dimensionless parameters for the cell energy were taken from a previous study using a vertex model for an MDCK monolayer^[@R49]^. Using length and force scales of the cells and substrate we recover the dimensional values. Other parameters, including purse string tension, protrusion force and focal adhesion binding rates were chosen to qualitatively match wound closure dynamics and traction force maps.

Using displacements in the substrate mesh we can interpolate a displacement field on a square grid, and use finite difference discretization to calculate elastic stress and strain. We measure the total work during wound closure as the amount of strain energy within a thickness of 8 μm of the wound border. For a full description of the model see the [Supplementary Information](#SD1){ref-type="supplementary-material"}.

Statistical Tests {#S21}
-----------------

All statistical comparisons between two distributions were done with a two-sided t-test. When distributions are presented as a single value with error bars, the value is the mean of the distribution, and the error bars are the standard deviations. We use the symbols \*, \*\*, and \*\*\* for p\< 0.05, 0.01, and 0.001 respectively. When fitting lines to data, we quote the p-value as significance values to rejections of the null hypothesis.

Data Availability {#S22}
-----------------

Data that support plots and other findings within this manuscript are available from the corresponding authors upon reasonable request.

Code Availability {#S23}
-----------------

Custom codes that were used to analyze experimental data within this manuscript are available from the corresponding authors upon reasonable request.

Supplementary Material {#SM1}
======================
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![Monolayer Viscoelasticity Depends on Substrate Rigidity\
(a-top) Schematic of experimental setup showing laser ablation of an epithelial sheet and subsequent sheet retraction velocity, *v*. Star marks location of ablation. Cell monolayers adhere to collagen covalently bound to polyacrylamide substrates. Fluorescent particles are embedded within the polyacrylamide substrate allowing the calculation of traction forces. (a-bottom) Kelvin-Voigt model used to quantify retraction. (b) DIC images immediately after ablation on a 1.3 kPa substrate. Scale bar is 25 μm. (c) PIV of initial deformation of the monolayer 0.5s after ablation, compared to immediately prior to ablation. Red star indicates the position of ablation. (d) Average monolayer retraction rate over time and viscoelastic timescale, *τ*~*0*~, representative of the ratio between monolayer viscosity *η*~*m*~ and elasticity *E*~*m*~ within a Kelvin-Voigt model. (e) *τ*~*0*~ is a function of substrate elasticity, *E* (N~total~=38). Error bars are mean +/− standard deviation.](nihms-1522698-f0001){#F1}

![F-actin Architecture Varies with Wound Size and with Substrate Stiffness.\
(a) F-actin (red), cadherin (blue), and paxillin (green) stains for a wound closing on a 4.3 kPa substrate. (b) F-Tractin stably transfected in an MDCK monolayer during healing. Ablation occurs at t=0 min. Outlined is the wound area *A*, and the area of the wound and lamellipodial protrusions, *A*~*L*~. This yields the fraction of wound area covered by lamellipodia, *ψ* = (*A*~*L*~ − *A*)/*A*~*L*~. (c) Single cells within monolayers expressing LifeAct during healing form either lamellipodia (LP-top) or a purse string (PS-bottom). Stars indicate positions of ablations. Dotted lines show regions used for kymograph analysis. Kymographs (right) indicate the rate of protrusion by both lamellipodium and purse string. (d) Example of lamellipodial fraction ψ as a function of wound area *A* on a 12.2 kPa substrate with maximimal lamellipodial area fraction *ψ*~*max*~. Changes in *ψ* for *A\>A*(*ψ*~*max*~), vertical line, originate from the maturation of lamellipodia. (d-inset) The purse string fraction, 1- *ψ*~*max*~, as a function of substrate stiffness, *E* (N=32). Dashed line is line of best fit with p\<0.001. (e) Percent of cells at wound boundary closing via lamellipodia (LP) versus purse string (PS) as determined by eye. (f) F-actin image of wound treated with blebbistatin has pronounced lamellipodial protrusions. (g) F-actin image of wound treated with CK666 has an enhanced purse string. (h) Purse string fraction across drug treatments of wounds closing on 12.2 kPa substrates. (N~control~= 9, N~bleb~= 3, N~SMIFH2~=6, and N~CK666~=5). Scale bars are 25 μm. Error bars are mean +/− standard deviation.](nihms-1522698-f0002){#F2}

![Purse String Coordinates with Lamellipodia to Maintain Closure Time.\
(a) DIC images of epithelial wound closure over time on an 8.5 kPa substrate. Red arrows point to boundaries between purse string and lamellipodia. (b) PIV showing accumulated strain of DIC images in (a). (c) Wound area over time, indicating the initial wound size A~0~, and exponential decay constants *τ*~*1*~ and *τ*~*2*~, where A = A~0~e^−*t*/*τ*^. (d) *τ*~*1*~ as a function of substrate stiffness (N=36). (e) *τ*~*1*~ as a function of substrate stiffness separating the samples from (d) into predominantly purse string samples (PS) or lamellipodial crawling (LP). (f) Strain rates during closure on very soft (*E*=1.8 kPa) and stiff (*E*=12.2 kPa) gels show difference in sensitivity to myosin-inhibition by blebbistatin (*E*=1.8kPa: control N=3, 10μM Bleb N=3, 40μM Bleb N=2; *E*=12.2kPa: control N=4, 40μM Bleb N=4). Error bars are mean +/− standard deviation.](nihms-1522698-f0003){#F3}

![Mechanical Work, but not Effective Power, is Architecture Dependent.\
(a) DIC image sequence of the closing of a wound on *E*=12.2 kPa and closing principally by purse string (PS). Scale bar is 50 μm. Associated traction force vectors (b) and strain energy maps (c) for the wound in (a) with definition of the wound perimeter, *L*, and wound thickness, 2*δ*~+/−~. (d) Total strain energy of a wound during closure decreases with time at a constant rate or effective power P\*. (e) P\* is independent of wound phenotype; *E=*12.2 kPa control is split into LP (N=12) (*ψ*~*max*~\>0.3) or PS (N=8) (*ψ*~*max*~\<0.3) subsets. (f) Wound perimeter *L* decreases linearly with time. Change in perimeter with time determines closure velocity *v*. (g) Wounds maintain a constant energy per unit length during closure. (h) Wound energy densities *W/L* and closure velocity (i) for LP or PS subsets. (j) Effective power, P, calculated from *W*/*L* × *v*, is independent of wound phenotype. Solid lines in (h-j) represent the average value for all control samples (N=20) before creating LP and PS subsets. (k-m) Wound energy densities, velocities, and effective powers for CK666 (N=8) and Blebbistatin treated monolayers (N=11). Dashed lines are average values for control samples, indicating that both drug treatments decrease mechanical work for a wound. Error bars are mean +/− standard deviation.](nihms-1522698-f0004){#F4}

![F-actin is Conserved During Lamellipodial to Purse String Transition.\
(a) Montage of fluorescent F-actin within a single cell in a MDCK monolayer on a 12.2 kPa substrate showing a transition from lamellipodial crawling to purse string. (b) Kymograph of F-tractin intensities, measuring the quantity of F-actin along the dashed line in (a). Regions outlined are for the cell body (CB), the purse string (PS) and the lamellipodium (LP). (c) The spatial sum of F-actin fluorescence per unit time for the regions outlined in (b). The ratio of mass flux into the purse string m~PS~ and out of the lamellipodium m~LP~ shows correlation in F-actin transfer. (d) F-actin fluorescence intensity integrated over the time series in (c). The decrease in F-actin from the lamellipodium is consistent with the sum of F-actin increases in the purse string and cell body. (e) Cartoon schematic of lamellipodial actin being incorporated into the lamellar band to form a purse string. From t=0 to t=t~f~ (when the wound is closed) the total F-actin intensity along the wound boundary (f) decreases, but the actin density (*ρ*=*I*~*γ*~*/L*) increases (g). Lines are average and grey regions are standard deviation of (N=4). Super-resolution images of F-actin (h) and myosin (i) of a cell at the leading edge. Myosin localizes to lamellar band. Scale bar is 5 μm. (j) In the lamella, the total myosin intensity *I*~*myo*~ scales with the total amount of actin. (k) Force *T*=*W/L* depends on actin content of purse string in CK666 treated wounds (N=7). Red dots are from one sample. Error bars are mean +/− standard deviation.](nihms-1522698-f0005){#F5}

![Differential friction is necessary to balance effective power.\
(a) Schematic of vertex model and inset where cells at the leading edge can either exhibit purse string or lamellipodial crawling. (b) Spatial distribution of strain energy measured through the simulation during closure. (c) Vertex model wound area dependence on time. (d) Strain energy-perimeter relation and wound closure velocity. (e) Differences in unbinding probabilities *k*~*off*~^*PS*^=0.083 min^−1^ (blue) and *k*~*off*~^*LP*^=0.208 min^−1^(green) lead to differences in focal adhesion lifetimes. (e-inset) Equal focal adhesion off-rates *k*~*off*~^*PS*^= *k*~*off*~^*LP*^=0.208 min^−1^ lead to equal focal adhesion lifetimes. (f) Decay time τ~1~ as a function of substrate stiffness (*E*=1 kPa N~LP~=26, N~PS~=16; *E*=2 kPa N~LP~=29, N~PS~=13; *E*=4 kPa N~LP~=24, N~PS~=18; *E*=8 kPa N~LP~=22, N~PS~=20; *E*=16 kPa N~LP~=24, N~PS~=18). (g-i) Energy density, velocity, and effective power for wounds exhibiting either purse string or lamellipodial crawling. *k*~*off*~^*LP*^\>*k*~*off*~^*PS*^ for *E*=4kPa (N~LP~=24, N~PS~=18). (j) The effective power of wounds on *E*=4 kPa substrate is not balanced between LP and PS if *k*~*off*~^*PS*^= *k*~*off*~^*LP*^ (N~LP~=14, N~PS~=6). Vertex model and confocal image show focal adhesions parallel to leading edge for purse strings (k) and perpendicular to leading edge for lamellipodia (l). Scale bars are 10μm. (m) Histograms of experimental focal adhesion angular distributions for cells exhibiting PS (N=257) and LP (N=342). (n) Mean focal adhesion size differs between PS (N=412) and LP (N=1075). (o) Experimentally and analytically calculated friction for LP and PS. Error bars are mean +/− standard deviation.](nihms-1522698-f0006){#F6}
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